Drug Approval | August 31, 2023
Ajanta Pharma receives USFDA for Topiramate Extended Release Capsules
Topiramate is the generic version of Supernus Pharmaceuticals’ Trokendi XR
Topiramate is the generic version of Supernus Pharmaceuticals’ Trokendi XR
The approval bolsters the company's Mycophenolate Mofetil portfolio
KEYTRUDA is the first immunotherapy approved in the EU for the first-line treatment of this patient population
Juergen Eckhardt joined Bayer in 2016 to help start Leaps by Bayer
This product will be manufactured at Lupin's Pithampur facility in India
In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers
Zinc Sulfate Injection is indicated in adult and paediatric patients as a source of zinc for parenteral nutrition
First PARP inhibitor approved in Japan to demonstrate clinically meaningful benefits in combination with a new hormonal agent
NIH’s candidate is based on the Adenovirus 4 backbone, largely used as a vector candidate in HIV and influenza vaccine clinical trials
The company has entered into a three-year Deferred Prosecution Agreement
Subscribe To Our Newsletter & Stay Updated
